Skip to main content
Have a personal or library account? Click to login
Assessment of Cyto/Genotoxicity of Irinotecan in V79 Cells Using the Comet, Micronucleus, and Chromosome Aberration Assay Cover

Assessment of Cyto/Genotoxicity of Irinotecan in V79 Cells Using the Comet, Micronucleus, and Chromosome Aberration Assay

Archives of Industrial Hygiene and Toxicology
Volume 61 (2010): Issue 1 (March 2010)
By: ,  ,   and    
Open Access
|Mar 2010
References

References

  1. Hsiang YH, Hertzberg R, Hecht S, Liu LF. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.1985;260:14873-8.
    Open DOISearch in Google Scholar
  2. Hsiang YH, Liu LF. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin.1988;48:1722-6.
    Search in Google Scholar
  3. Hertzberg RP, Caranfa MJ, Hecht SM. On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex.1989;28:4629-38.
    Open DOISearch in Google Scholar
  4. Kjeldsen E, Svejstrup JQ, Gromova H, Alsner J, Westergaard O. Camptothecin inhibits both the cleavage and religation reactions of eucaryotic DNA topoisomerase I.1992;228:1025-30.
    Open DOISearch in Google Scholar
  5. Bailly C. Homocamptothecins: potent topoisomerase I inhibitors and promising anticancer drugs.2003;45:91-108.
    Open DOISearch in Google Scholar
  6. Eng WK, Faucette L, Johnson RK, Sternglanz R. Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin.1988;34:755-60.
    Search in Google Scholar
  7. Slichenmyer WJ, Rowinsky EK, Donehower RC, Kaufmann SH. The current status of camptothecin analogues as antitumor agents.1993;85:271-91.
    Open DOISearch in Google Scholar
  8. Rothenberg ML, Kuhn JG, Schaf LJ, Drengler RL, Eckhardt SG, Villalonacalero MA, Hammond L, Miller LL, Petit RG, Rowinsky EK, Vonhoff DD. Alternative dosing scheduels for Irinotecan.1998;12(Suppl 6):68-71.
    Search in Google Scholar
  9. Li LH, Fraser TJ, Olin EJ, Bhuyan BK. Action of camptothecin on mammalian cells in culture.1972;32:2643-50.
    Search in Google Scholar
  10. Irinotecan. USP DI. Vol. 1, Drug information for the health care professional. 20ed. Englewood (CO): Micromedex Inc.; 2000.
    Search in Google Scholar
  11. Singh N, McCoy M, Tice R, Schneider E. A simple technique for quantification of low levels of DNA damage in individual cells.1988;175:184-91.
    Open DOISearch in Google Scholar
  12. Houghton PJ, Stewart CF, Thompson J, Santana VM, Furman WL, Friedman HS. Preclinical and clinical results with Irinotecan - extending principles learned in model system to clinical trails design.1998;12(8 Suppl 6):84-93.
    Search in Google Scholar
  13. Yoshida A, Ueda T, Wano Y, Nakamura T. DNA damage and cell killing by camptothecin and its derivative in human leukemia HL-60 cells.1993;84:566-73.
    Open DOISearch in Google Scholar
  14. Kopjar N, Želježić D, Lucić Vrdoljak A, Radić B, Ramić S, Milić M, Gamulin M, Pavlica V, Fučić A. Irinotecan toxicity to human blood cells: relationship between various biomarkers.2007;100:403-13.
    Open DOISearch in Google Scholar
  15. Sánchez-Alcázar JA, Bradbury DA, Brea-Calvo G, Navas P, Knox AJ. Camptothecin-induced apoptosis in non-small cell lung cancer is independent on cyclooxygenase expression.2003;8:639-47.
    Open DOISearch in Google Scholar
  16. Ciesielski MJ, Fenstermaker RA. Synergistic cytotoxicity, apoptosis and protein linked DNA breakage by etoposide and camptothecin in human U87 glioma cells: dependence on tyrosine phosphorilation.1999;41:223-34.
    Open DOISearch in Google Scholar
  17. Minderman H, Conroy JM, O Loughlin KL, McQuaid D, Quinn P, Li S, Pendyala L, Nowak NJ, Baer MR.andirinotecan-induced changes in expression profiles of cell cycle and apoptosis-associated genes in acute myeloid leukemia cells.2005;4:885-900.
    Open DOISearch in Google Scholar
  18. Guichard S, Arnould S, Hennebelle I, Bugat R, Canal P. Combination of oxaliplatin and irinotecan on human colon cancer cell lines: activityand.2001;12:741-51.
    Open DOISearch in Google Scholar
  19. Gibson RJ, Bowen JM, Inglis MR, Cummins AG, Keefe DM. Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer.2003;18:1095-100.
    Open DOISearch in Google Scholar
  20. Gibson RJ, Keefe DMK, Thompson FM, Clarke JM, Goland GJ, Cummins AG. Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats.2002;47:2751-7.
    Open DOISearch in Google Scholar
  21. Daza P, Torreblanca J, Garcia-Herdugo G, Moreno FJ. DNA strand-breaks induced by the topoisomerase I inhibitor camptothecin in unstimulated human white blood cells.2002;26:707-13.
    Open DOISearch in Google Scholar
  22. Godard T, Deslandes E, Sichel F, Poul JM, Gauduchon P. Detection of topoisomerase inhibitor-induced DNA strand breaks and apoptosis by the alkaline comet assay.2002;520:47-56.
    Open DOISearch in Google Scholar
  23. Gradzka I, Skierski J, Szumiel I. DNA repair, cell cycle progression and cell death following Camptothecin treatment in two murine lymphoma L5178Y sublines.1998;16:239-52.
    Open DOISearch in Google Scholar
  24. Ollikainen T, Knuuttila A, Suhonen S, Taavitsainen M, Jekunen A, Mattson K, Linnainmaa K.sensitivity of normal human mesothelial and malignant mesothelioma cell lines to four new chemotherapeutic agents.2000;11:93-9.
    Open DOISearch in Google Scholar
  25. Anderson RD, Berger NA. Mutagenicity and carcinogenicity of topoisomerase-interactive agents.1994;309:109-42.
    Open DOISearch in Google Scholar
  26. Voight W, Matsui S, Yin MB, Burhans WC, Minderman H, Rustum YM. Topoisomerase- I inhibitor SN-38 can induce DNA damage and chromosomal aberrations independent from DNA synthesis.1998;18(5A):3499-505.
    Search in Google Scholar
  27. Del Bino G, Lassota P, Darzynkiewicz Z. The S-phase cytotoxicity of camptothecin.1991;193:27-35.
    Open DOISearch in Google Scholar
  28. Tsao YP, D'Arpa P, Liu LF. The involvement of active DNA synthesis in camptothecin-induced Garrest: altered regulation of p34cdc2/cyclin B.1992;52:1823-9.
    Search in Google Scholar
  29. Mahabir AG, Benthem Jv, Korsten H, Lynch AM, Bailey L, de Vries A, Hendriksen CF, van Steeg H. Detecting genotoxic effects of potential clastogens: Anstudy using the transgenic lacZ plasmid and the MutaTM Mouse model.2008;652:151-7.
    Open DOISearch in Google Scholar
  30. Holmström M, Winters V. Micronuclei induction by camptothecin and amsacrine in bone marrow of male and female CD-1 mice.1992;7:189-93.
    Open DOISearch in Google Scholar
  31. Bacher LC, Allen JW, Harrington-Brock K, Campbell JA, Moore MM. Genotoxicity of inhibitors of DNA topoisomerase I (camptothecin) and II (m-ASA)and.1990;5:541-7.
    Open DOISearch in Google Scholar
  32. Hardman WE, Moyer MP, Cameron IL. Consumption of an omege-3 fatty acids product, INCELL AAFA™, reduced side-effects of CPT-11 (irinotecan) in mice.2002;86:983-8.
    Open DOISearch in Google Scholar
  33. Aydemir N, Bilaloglu R. Genotoxicity of two anticancer drugs; gentamicine and topotecan, in mouse bone marrow.2003;537:43-51.
    Open DOISearch in Google Scholar
  34. Attia SM, Aleisa AM, Bakheet SA, Al-Yahya AA, Al-Reyaie SS, Ashour AE, Al-Shabanah OA. Molecular cytogenetic evaluation of the mechanism of micronuclei formation induced by camptothecin, topotecan and irinotecan.2009;50:145-51.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/10004-1254-61-2010-1967 | Journal eISSN: 1848-6312 (formerly 0004-1254) | Journal ISSN: 0004-1254
Journal RSS Feed
Language: English, Croatian
Page range: 1 - 9
Published on: Mar 25, 2010
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services
Keywords:
alkaline comet assay,
antineoplastic drug,
cell cultures,
DNA and cytogenetic damage,
topoisomerase
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2010 Vilena Kašuba, Ružica Rozgaj, Marija Gamulin, Ivančica Trošić, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons License.

Volume 61 (2010): Issue 1 (March 2010)
Next article